2020 Attendee Profile

**List updated as of 1/15/2020

 

Title Company
Bus Dev Mgr Agilent Technologies
Mgr Bus Dev Agilent Technologies
Sales Mgr Agilent Technologies
Staff Ajinomoto Co Inc
President Aligos Therapeutics
Dir Clinical Research Alnylam Pharmaceuticals
Dir Process Chemistry Alnylam Pharmaceuticals
Dir Regulatory Affairs Alnylam Pharmaceuticals
Distinguished Investigator Alnylam Pharmaceuticals
VP Process & Analytical Sciences Alnylam Pharmaceuticals
Dir Clinical Dev Arrowhead Pharmaceuticals Inc
Sr Scientist Arrowhead Pharmaceuticals Inc
Bus Dev Mgr Bachem Americas Inc
Marketing Coordinator Bachem Americas Inc
Sr Dir Bus Dev Bachem Americas Inc
Assoc Dir ASO Process Engineering & Mfg Biogen
Scientist II Biogen
Sr Process Engineer III Biogen
Dir Corp Strategy & Dev Boehringer Ingelheim GmbH
Assoc Prof of Neurosurgery Brigham & Womens Hospital
Assoc Dir Broad Institute
Graduate Student Broad Institute
Research Assoc Broad Institute
Scientist Cardior Pharmaceuticals GmbH
Prof CHA Univ
Chief of Operations ChemGenes Corp
Principal CMC Tyndall Consultant
Greenberg Starr Prof Cornell Univ
Prof Physiology & Biophysics & Dir Cornell Univ
Assoc Dir Pre Clinical Oncology Dicerna Pharmaceuticals Inc
VP Regulatory Affairs Dicerna Pharmaceuticals Inc
Dir Preclinical Drug Safety Eisai Inc
Sr Principal Scientist Eisai Inc
Founder & Principal Email Address Only
Staff EMD Serono
Sr Dir Program Management Exicure
Staff GeneDesign Inc
Research Scientist & Deputy GM Green Cross R&D Ctr
Assoc Prof Icahn School of Medicine at Mount Sinai
CoFounder & CEO Individual Consultant
Dir Individual Consultant
Principal Consultant Individual Consultant
Scientist Individual Consultant
VP Strategy & Corp Dev Individual Consultant
Asst Dir Mfg & Operations Ionis Pharmaceuticals Inc
CEO Ionis Pharmaceuticals Inc
Principal Scientist Ionis Pharmaceuticals Inc
Managing Dir & Co Founder IPQ Analytics LLC
Tech Manager JHL Biotech Inc
Dir Kairos Bioconsulting
Principal Scientist Kairos Bioconsulting
Prof Leiden Univ
Oncologist London Regional Cancer Ctr
Administrative Asst Lyophilization Technology Inc
Research Scientist Massachusetts Institute of Technology
Assoc Prof Maxillofacial Surgery Svcs MFSS
Assoc Prof MD Anderson Cancer Ctr
Dir Research Moderna Therapeutics
Sr Dir Discovery Chemistry Moderna Therapeutics Inc
Patent Agent Morrison & Foerster LLP
Section Chief NCNP
Student Northeastern Univ
Investigator Novartis Institutes for BioMedical Research Inc
Sr Scientist Novartis Pharmaceuticals Corp
VP & Head Novo Nordisk Research Ctr China
Chief Business Officer Nuritas
Founder & CEO OliX Pharmaceuticals
Sr Scientist Orion Pharma
President & Principal Consultant Orvieto Consulting LLC
Account Exec Pace Analytical Life Sciences
Assoc Dir Pace Analytical Life Sciences
Marketing Coordinator Pace Analytical Life Sciences
President PolyPeptide Grp
Dir Pharmaceutics ProQR Therapeutics NV
Principal Scientist PTC Therapeutics Inc
Principal Scientist Q State Biosciences
VP of Scientific Affairs Q State Biosciences
VP R&D Q State Biosciences
CSO Quark Pharmaceuticals
Sr VP Pharmaceutical Development Quark Pharmaceuticals Inc
Principal Scientist Roche Innovation Ctr Copenhagen
Principal Scientist Roche Innovation Ctr Copenhagen
Sr Dir Alliance Management Sanofi Germany GmbH
Events Mgr SCIEX
Chair & Prof Scripps Research Institute
Consultant Sirnaomics Inc
CTO Sirnaomics Inc
President & CSO Sirnaomics Inc
CoFounder & CSO & VP Spring Bank Pharmaceuticals Inc
Dir Marketing STA Pharmaceutical A WuXi AppTec Co
CEO Stoke Therapeutics
CEO Sungkyunkwan Univ
Graduate Student Sungkyunkwan Univ
Principal Scientist Sungkyunkwan Univ
Prof Sungkyunkwan Univ
Assoc Dir Takeda Pharmaceutical Co Ltd
Assoc Scientific Fellow Takeda Pharmaceuticals Inc
Marketing TriLink BioTechnologies
Research Asst Prof Tufts Univ
Dir ChemBioPharm Univ of Bordeaux II
Graduate Research Assistant Deep Learning Univ of Central Florida
Distinguished Prof Univ of Colorado Boulder
Sr Graduate Student Univ Of Massachusetts
Assoc Prof Univ of Michigan
Asst Prof Pediatrics Univ of Minnesota Twin Cities
Prof Medicine & Genetics & Assoc Dean Univ Of Minnesota Twin Cities
Dir Univ of North Carolina Chapel Hill
Prof Univ of Texas Dallas
Staff Univ of Tokyo
Prof & Sr Scientist Univ of Toronto
Principal Exec VP Vox Medica Inc
Principal Application Chemist Waters Corp
Sr VP Drug Discovery WAVE Life Sciences
Sr Marketing Manager WuXi AppTec Sales RSD
President & CEO ZATA Pharmaceuticals Inc

 

2020 Event Features:

  • 200+ Participants
  • 2 Expanded Conferences
  • 2 Symposia
  • New Programming on AI for Drug Discovery
  • Dedicated Poster Viewing Sessions
  • Educational Short Courses
  • Dedicated Exhibit Hall Hours and Networking Functions

 

2019 Attendee Profile


OPT Congress 2019
Attended by more than 130 unique companies

The Fourth Annual “Oligonucleotide & Precision Therapeutics” (OPT Congress) was held March 26-28, 2019 at the Hyatt Regency Cambridge, in Cambridge, Massachusetts.

More than 200 industry leaders from 14 different countries joined the 2-day program dedicated to Oligonucleotide Discovery & Delivery, CMC and Regulatory Strategies. In addition, we delivered two in-depth symposiums focusing on Drug Discovery for Rare Diseases and New Frontiers in Gene Editing and Repair. NEW for 2020 we will be assessing the impact of AI on drug discovery.

The congress participation was represented well with 55% attended by executives. With more than 65% of the audience from biotech, another 15% from pharma, and the event represented by 130+ unique organizations, this event will continue to gather a diverse body of attendees from around the world to network, share ideas, and discuss cutting-edge science and technology.

Company Type
Title Type


2019 Event Features

  • 200+ Participants
  • 2 Conferences
  • 2 Symposium
  • Dinner Courses
  • Dedicated Poster Viewing Sessions
  • Dedicated Exhibit Hall Hours and Networking Functions

Hear what a few people had to say about OPT Congress 2019

“Well balanced content, perfectly executed logistics.”
     Dmitry S., PhD, CTO, Sirnaomics

“The scientific quality of the presentations was very high and the opportunities for networking were excellent.”
Ekkehard L., PhD, Senior Director, R&D Alliance Management, Sanofi

With special thanks to our Executive Advisory Board who help to shape the program:

  • Arthur Levin, PhD, Executive Vice President, Research and Development, Avidity Biosciences
  • Muthiah (Mano) Manoharan, PhD, Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals
  • Dmitry Samarsky, PhD, CTO, Sirnaomics
  • Lubo Nechev, PhD, Vice President Process and Analytical Sciences, Alnylam Pharmaceuticals
video
photo


RNA Targeting with Antisense Oligonucleotides: Present and Future
Geary_RichardRichard S. Geary, PhD, Senior Vice President, Development, Ionis Pharmaceuticals

Key Contacts

For content and speaker suggestions
Oligonucleotide Discovery and Development

Gemma Smith
Senior Director, Conferences
Cambridge Healthtech Institute
T: +447754.518.131
E: gsmith@cambridgeinnovationinstitute.com

For content and speaker suggestions

Rare Diseases/Artificial Intelligence
Tanuja Koppal, PhD
Senior Director, Conferences
Cambridge Healthtech Institute
E: tkoppal@healthtech.com

For partnering and sponsorship information:

Carolyn Benton
Business Development Manager
Cambridge Healthtech Institute
T: 781-972-5412
E: cbenton@healthtech.com

For media partnerships:

Dan Miller, Marketing Manager
Cambridge Healthtech Institute
T: (+1) 781.972.5492
E: dmiller@healthtech.com


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag


Download Brochure